This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers none of which have influenced the event content or the choice of speakers. Sessions delivered with input from these organisations will be marked as such on the programme once released and a list of all sponsors and exhibitors will be published shortly.
Professor Derek Connolly
BSc[Hons] MB ChB[Edin] PhD[Cantab] DSc[Hon] FRCP FESC, Consultant Cardiologist, Birmingham City & Sandwell Hospitals
Professor Derek Connolly is a Consultant Cardiologist and the Director of Research and Development at Birmingham City Hospital. He holds honorary academic positions at both Aston medical school and at the Institute of Cardiovascular Sciences, University of Birmingham, UK.
He trained in Edinburgh, Cambridge, London and San Diego where he was a Carnegie Scholar. He has a first class degree in Pharmacology from the University of Edinburgh where he was the Brunton medallist and Keasbey Bursary holder. His BHF funded PhD in molecular cardiology is from the University of Cambridge. He is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine. He developed one of the UKs first primary angioplasty programmes, and one of the UKs largest cardiac CT programmes. He is a council member of the British Primary Care Cardiovascular Society.
He was on the design and naming team of the forthcoming super hospital, the Midland Metropolitan University Hospital which will open 2024. His main interests are in the detection and treatment of coronary artery disease with a particular emphasis on both primary and secondary prevention.
He was recently awarded an honorary doctorate by Aston University for his contributions to medical science.
